IP Library Patent Application 12099009
Patent Application
App. No. 12/099,009

HIGH-PRESSURE REFOLDING OF PROTEINS IN THE PRESENCE OF BINDING PARTNERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/099,009
Filed
Apr 7, 2008
Art Unit
1656
USPC
530/402
Abstract

Methods for producing biologically active protein from aggregated and/or denatured proteins which comprise subjecting the protein to high hydrostatic pressure in the presence of a ligand or specific binding agent are disclosed. The ligand can be a macromolecule, such as another protein, a nucleic acid, or other macromolecules, or the ligand can be a small organic molecule.

Claims (36)

1 . A method for producing biologically active protein from a mixture comprising aggregated or denatured protein, comprising:

a) adding a specific binding agent for the biologically active protein to the mixture;

b) subjecting the mixture to high hydrostatic pressure for a period of time sufficient to form biologically active protein; and

c) reducing the pressure to atmospheric pressure.

2 . The method of claim 1 , wherein the specific binding agent is a small organic molecule.

3 . The method of claim 2 , wherein the small organic molecule is a rigid molecule.

4 . The method of claim 2 , wherein the small organic molecule is a flexible molecule.

5 . The method of claim 1 , wherein the specific binding agent is a polypeptide.

6 . The method of claim 1 , wherein the specific binding agent is a nucleic acid molecule.

7 . A method for producing biologically active protein from a mixture comprising aggregated or denatured protein, comprising:

a) adding a homopolymer or non-naturally-occurring polymer which binds to the biologically active protein to the mixture;

b) subjecting the mixture to high hydrostatic pressure for a period of time sufficient to form biologically active protein; and

c) reducing the pressure to atmospheric pressure.

8 . The method of claim 7 , wherein the homopolymer or non-naturally occurring polymer binds specifically to the biologically active protein.

9 . The method of claim 7 , wherein the homopolymer or non-naturally occurring polymer binds preferentially to the biologically active protein over inactive, denatured, or aggregated protein.

10 . The method of claim 9 , wherein the homopolymer or non-naturally occurring polymer binds preferentially to the biologically active protein via electrostatic interaction.

11 . The method of claim 9 , wherein the homopolymer or non-naturally occurring polymer binds preferentially to the biologically active protein via hydrophobic interaction.

12 . The method of claim 9 , wherein the homopolymer or non-naturally occurring polymer is a homopolymer.

13 . The method of claim 9 , wherein the homopolymer or non-naturally occurring polymer is a non-naturally occurring polymer.

14 . The method of claim 9 , wherein the homopolymer or non-naturally occurring polymer is dextran sulfate.

15 . A method for producing biologically active protein from a mixture comprising a first aggregated or denatured protein, comprising:

a) adding a second aggregated or denatured protein to the mixture; and

b) subjecting the mixture to high hydrostatic pressure for a period of time sufficient to form biologically active protein, wherein said first and second aggregated or denatured proteins specifically interact under high pressure; and

c) reducing the pressure to atmospheric pressure.

16 . The method of claim 15 , further comprising:

d) separating the first and second proteins.

17 . The method of claim 16 , wherein the separating of the first and second proteins is performed by affinity chromatography, HPLC, dialysis, ion exchange chromatography, size exclusion chromatography, reverse-phase chromatography, ammonium sulfate precipitation, or electrophoresis.

18 . The method of claim 15 , wherein one of the first or second proteins is a chaperone protein.

19 . The method of claim 15 , wherein the first and second proteins continue to interact after the pressure is reduced to atmospheric pressure.

20 . The method of claim 19 , wherein the first and second proteins form a heterodimer in their biologically active state.

21 . The method of claim 19 , wherein one of the first and second proteins is an enzyme and the other is a substrate for the enzyme.

22 . The method of claim 19 , wherein one of the first and second proteins is an enzyme and the other is an inhibitor of the enzyme.

23 . The method of claim 19 , wherein one of the first and second proteins is an enzyme and the other is a regulator or modulator of the enzyme.

24 . The method of claim 19 , wherein one of the first and second proteins is a receptor and the other is a ligand for the receptor.

25 . The method of claim 24 , wherein one of the first and second proteins is a receptor and the other is an agonist for the receptor.

26 . The method of claim 24 , wherein one of the first and second proteins is a receptor and the other is an antagonist for the receptor.

Assignments (4)
SECURITY AGREEMENT Recorded Aug 6, 2009
From: BAROFOLD, INC.
To: PEIERLS, E. JEFFREY; THE PEIERLS FOUNDATION, INC.; UD ETHEL F. PEIERLS CHARITABLE LEAD TRUST; UW E.S. PEIERLS FOR EJP ART VI-ACCUM; UW E.S. PEIERLS FOR BEP ART VI-ACCUM; UW JENNIE PEIERLS FOR E.J. PEIERLS; UW JENNIE PEIERLS FOR B.E. PEIERLS; UD E.S. PEIERLS FOR E.F. PEIERLS ETAL; UD J.N. PEIERLS FOR E.J. PEIERLS; UD J.N. PEIERLS FOR B.E. PEIERLS; UD E.F. PEIERLS FOR E.J. PEIERLS; UD E.F. PEIERLS FOR B.E. PEIERLS; PEIERLS, BRIAN ELIOT; BOULDER VENTURES IV, L.P.; BOULDER VENTURES IV (ANNEX), L.P.; HBM BIOVENTURES (CAYMAN) LTD.; SMARTT, ROBERT W.; JOHNSTON-SMARTT, MARY CAROLE; BARER, SOL J.; GC&H INVESTMENTS, LLC; BB-CC VENTURES, LLC; MACKS MANAGED INVESTMENT I, LLC; CARUTHERS, MARVIN; SNITMAN, DAVID; ANDERSON, ROBERT K.; DRYDEN, SAM
Reel/Frame 023065/0066 →
CORRECTIVE ASSIGNMENT TO CHANGE THE EXECUTION DATE ON THIS PATENT FILING. EXECUTION DATE ON IP FILING SHOULD BE 06/23/2009 (SAME AS IP AGREEMENT), PREVIOUSLY RECORDED ON REEL 022892 FRAME 0377. Recorded Jul 31, 2009
From: BAROFOLD INC.
To: SILICON VALLEY BANK
Reel/Frame 023044/0107 →
SECURITY AGREEMENT Recorded Jun 30, 2009
From: BAROFOLD INC.
To: SILICON VALLY BANK
Reel/Frame 022892/0377 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2008
From: SEEFELDT, MATTHEW B.; HESTERBERG, LYNDAL K.; RANDOLPH, THEODORE W.; CARPENTER, JOHN F.
To: BAROFOLD, INC.
Reel/Frame 020968/0329 →